Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10093008 | 0.93 | CNR2 (0.64) | CNR1CNR2 | |
| SCHEMBL15142732 | 0.91 | CNR1 (0.64) | CNR1CNR2 | |
| SCHEMBL10093007 | 0.90 | CNR2 (0.77) | CNR1CNR2 | |
| SCHEMBL10093009 | 0.89 | CNR1 (0.62) | CNR1CNR2 | |
| SCHEMBL10093012 | 0.88 | CNR1 (0.67) | CNR1CNR2 | |
| SCHEMBL15142718 | 0.86 | CNR2 (0.66) | CNR1CNR2 | |
| SCHEMBL670677 | 0.85 | CNR1 (0.63) | CNR1CNR2 | |
| SCHEMBL15126358 | 0.83 | CNR1 (0.62) | CNR1CNR2 | |
| SCHEMBL670365 | 0.83 | CNR1 (0.68) | CNR1CNR2 | |
| SCHEMBL15142731 | 0.82 | CNR1 (0.57) | CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012024670-A2 | COMPOSITION AND METHODS FOR TREATING GLIOBLASTOMA | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2012-02-23 | — | — | WO | disclosed |